- Home
- BEAT vs LGL Comparison
BEAT vs LGL Comparison
Compare BEAT & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- LGL
- Stock Information
- Founded
- BEAT 2015
- LGL 1917
- Country
- BEAT United States
- LGL United States
- Employees
- BEAT N/A
- LGL N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- LGL Industrial Machinery/Components
- Sector
- BEAT Technology
- LGL Technology
- Exchange
- BEAT Nasdaq
- LGL Nasdaq
- Market Cap
- BEAT 33.1M
- LGL 38.5M
- IPO Year
- BEAT 2021
- LGL N/A
- Fundamental
- Price
- BEAT $1.03
- LGL $6.95
- Analyst Decision
- BEAT Buy
- LGL
- Analyst Count
- BEAT 1
- LGL 0
- Target Price
- BEAT $8.00
- LGL N/A
- AVG Volume (30 Days)
- BEAT 118.9K
- LGL 2.7K
- Earning Date
- BEAT 08-13-2025
- LGL 08-14-2025
- Dividend Yield
- BEAT N/A
- LGL N/A
- EPS Growth
- BEAT N/A
- LGL N/A
- EPS
- BEAT N/A
- LGL 0.04
- Revenue
- BEAT N/A
- LGL $4,178,000.00
- Revenue This Year
- BEAT N/A
- LGL N/A
- Revenue Next Year
- BEAT N/A
- LGL N/A
- P/E Ratio
- BEAT N/A
- LGL $171.32
- Revenue Growth
- BEAT N/A
- LGL 6.34
- 52 Week Low
- BEAT $0.91
- LGL $5.39
- 52 Week High
- BEAT $3.48
- LGL $9.74
- Technical
- Relative Strength Index (RSI)
- BEAT 40.15
- LGL 40.90
- Support Level
- BEAT $0.91
- LGL $6.92
- Resistance Level
- BEAT $1.32
- LGL $7.15
- Average True Range (ATR)
- BEAT 0.12
- LGL 0.12
- MACD
- BEAT 0.01
- LGL -0.05
- Stochastic Oscillator
- BEAT 29.27
- LGL 8.93
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.